1400MG Rituximab Solution For Subcutaneous Injection

We are a noteworthy manufacturer of 1400MG Rituximab Solution For Subcutaneous Injection in the market. It is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy. Maintenance therapy using 1400MG Rituximab Solution For Subcutaneous Injection is indicated for the treatment of follicular lymphoma patients responding to induction therapy.